
Overview
Aurora Polska is one of the leading producers of medical cannabis and acts as a professional partner for physicians and other medical specialists. Through its Aurora Academy platform, it offers lectures and educational materials on therapy, not only product-related. Publications are regularly expanded with Canadian and Western European materials.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $51,969 | |
| Profit allocation | Retained in reserve capital | |
| Loans and borrowings | $74,378 | |
| Foreign sales | 99.98% of revenue ($2,237,355) | |
| Revenue structure | Usługi wspierające sprzedaż produktów Aurora Europe | |
| Future lease and rent payments | $310,756 |
Filing timeliness
No financial statement for 2026 – the filing deadline has passed.
- 2026not filed
- 202530/09/2025
- 202318/12/2023
- 202212/10/2022
- 202115/10/2021
- 201909/10/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
- aurora-academy.plStrona głównaGoogle AnalyticsGoogle Tag ManagerApache
Authorized Representatives
Manner of representation
In the case of a one-person management board, the only member of the management board is authorised to make declarations of will on behalf of the company independently. If the management board is multi-member, each member of the management board is authorised to make declarations of will on behalf of the company independently; however, for legal acts concerning liabilities or dispositions exceeding PLN 30,000.00 (thirty thousand zloty), joint action by two members of the management board is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aurora Europe Gmbh | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-03-01.
51 1020 5561 0000 3402 3004 1613
18 1020 5561 0000 3602 3004 1624
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vitama S.A. | $4,287,087.38 | vitama.pl | ||
| Cosma S.A. | $3,421,832.81 | cosma.pl | ||
| Ever Pharma Poland sp. z o.o. | $3,054,922.01 | everpharma.com | ||
| Almirall sp. z o.o. | $2,488,510.66 | almirall.pl | ||
| Bioactive T sp. z o.o. | $1,599,993.10 | bioactivet.pl | ||
| Przedsiębiorstwo Farmaceutyczne Sulphur Busko Zdrój sp. z o.o. | $1,592,037.83 | sulphur.com.pl | ||
| Grand Medical Poland sp. z o.o. | $1,394,971.29 | grandmedical.pl | ||
| Ecoversea sp. z o.o. | $891,022.45 | coslab.pl | ||
| Goodwill Pharma Polska sp. z o.o. | $664,724.30 | goodwillpharma.com | ||
| Unipharm sp. z o.o. | $404,433.20 | unipharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-01-31 | Address change (Ul. Cybernetyki 10, 02-677, Warszawa → Ul. Prosta 51, 00-838, Warszawa) | |
| 2024-11-04 | Address change (Ul. Domaniewska 44, 02-672, Warszawa → Ul. Cybernetyki 10, 02-677, Warszawa) | |
| 2023-09-25 | Address change (Ul. Domaniewska 50, 02-672, Warszawa → Ul. Domaniewska 44, 02-672, Warszawa) | |
| 2022-10-27 | Address change (Ul. Adama Branickiego 15, 02-792, Warszawa → Ul. Domaniewska 50, 02-672, Warszawa) | |
| 2019-01-24 | Entered in the register |
FAQ
Last updated: 2026-10-05